Study identifies promising therapy to prevent relapses in rare neurological disease
An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in myelin oligodendrocyte glycoprotein antibody-associated disease ...
Aug 7, 2026
0
4

